Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeOur CompanyInnovative Medicine

      Johnson & Johnson Innovative Medicine

      Patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the potential medicines of tomorrow.

      Our diverse portfolio spans multiple therapeutic areas—Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

      We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.

      Are super-personalized solutions the future of healthcare?

      The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
      We innovate with purpose to lead where medicine is going. Innovation requires thinking differently so we continue to reimagine the entire research, development and delivery process.

      Cutting-edge technologies and expert insight help us understand and address the serious health problems of today and unlock the potential medicines of tomorrow. We pursue new pathways, collaborate closely with healthcare professionals, and decipher data to help people live fuller lives.


      We are driven by our bold vision to eliminate cancer. Together, we work diligently to get in front of cancer and will never settle until the disease is behind everyone.

      At Johnson & Johnson, we innovate with purpose to lead where medicine is going. We listen and learn with compassion to understand the needs of patients, caregivers, and healthcare professionals who remind us every day why we are working toward the elimination of cancer. Our aim is to not only take down disease, but to change and save lives. Our aim is to be in front of cancer.


      Driven by a relentless dissatisfaction with the status quo, our mission is to redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients with autoimmune disease.


      Our mission is to reduce the burden, disability and devastation caused by serious neuropsychiatric and neurodegenerative diseases.


      Cardiovascular diseases are the number one cause of death worldwide, leading to an estimated 31 percent of all deaths. We can help change this course.

      Pulmonary hypertension

      Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal life.


      Every day we dare to envision a brighter future.

      We stand by patients with courageous science to match their will. With relentless ingenuity, we aim to achieve extraordinary discoveries including gene therapy innovations. We won’t stop striving until we restore and preserve vision for those living with retinal diseases.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.